'Low risk tissues organs' presentation slideshows

FDA TSE Advisory Committee Meeting February 13, 2004; Topic 4D Minimizing the Risk of TSE in CDER - Regulated Products

FDA TSE Advisory Committee Meeting February 13, 2004; Topic 4D Minimizing the Risk of TSE in CDER - Regulated Products. Gerald M. Feldman, Ph.D. Division of Monoclonal Antibodies Office of Biotechnology Products Office of Pharmaceutical Science Center for Drug Evaluation and Research.

278 views • 12 slides